Previous studies have shown the expansions of monoclonal and oligoclonal T cells carrying clonal TCRγ and δ gene rearrangements in CML patients at diagnosis and during dasatinib therapy (22, 23). Here, TRGC1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.